Please Wait.....
Report
Global Veterinary Pain Management Market - Industry Trends and Forecast to 2030
Market Report I 2023-09-01 I 516 Pages I Data Bridge Market Research
Global veterinary pain management market is expected to reach USD 3,287,278.56 thousand by 2030 from USD 2,151,103.97 thousand in 2022 growing at the CAGR of 5.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation
Global Veterinary Pain Management Market, By Product Type (Analgesics, Corticosteroids, and Alpha 2 Agonists), Drug Type (Branded and Generic), Mode of Purchase (Prescription Based and OTC), Animal Type (Companion Animal and Production Animal), Pain Source (Chronic Pain, Acute Pain, Post-Operative Pain, and Dental Pain), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Parenteral, Oral, and Topical), End User (Veterinary Hospitals, Veterinary Clinics, Pet Shops, Animal Farms, Academic & Research Institutes, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Poland, Denmark, Sweden, Norwat, Funland, rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Taiwan, Vietnam, rest of Asia-Pacific, South Africa, Saudi Arabi, U.A.E., Egypt, Israel, Kuwait, Oman, Qatar, Bahrain, rest of Middle East and Africa, Brazil, Argentina, and rest of South America) - Industry Trends and Forecast to 2030
Overview of Global Veterinary Pain Management Market Dynamics
Driver
- Rising incidences of pet diseases
Restraint
- High costs of pet care
Opportunity
- Technological advancements for pain management
Market Players
Some of the major market players operating in the global veterinary pain management market are:
- Dechra Pharmaceuticals PLC
- Virbac
- Norbrook
- Durvet Animal Health Products
- Bimeda, Inc.
- Inovet ( A subsidiary of Orion Group)
- Chanelle Pharma
- Vetoquinol
- Elanco
- Merck & Co., Inc.
- Zoetis Services LLC
- Ceva Animal Health, LLC
TABLE OF CONTENTS
1 INTRODUCTION 61
1.1 OBJECTIVES OF THE STUDY 61
1.2 MARKET DEFINITION 61
1.3 OVERVIEW OF THE GLOBAL VETERINARY PAIN MANAGEMENT MARKET 61
1.4 CURRENCY AND PRICING 63
1.5 LIMITATIONS 63
1.6 MARKETS COVERED 64
2 MARKET SEGMENTATION 67
2.1 MARKETS COVERED 67
2.2 GEOGRAPHICAL SCOPE 68
2.3 YEARS CONSIDERED FOR THE STUDY 69
2.4 DBMR TRIPOD DATA VALIDATION MODEL 70
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 73
2.6 MULTIVARIATE MODELLING 74
2.7 MARKET END USER COVERAGE GRID 74
2.8 PRODUCT LIFELINE CURVE 75
2.9 DBMR MARKET POSITION GRID 76
2.10 VENDOR SHARE ANALYSIS 77
2.11 SECONDARY SOURCES 78
2.12 ASSUMPTIONS 78
3 EXECUTIVE SUMMARY 79
4 PREMIUM INSIGHTS 82
4.1 PESTEL ANALYSIS 83
4.2 PORTER'S FIVE FORCES 84
4.3 BRAND REVENUE ANALYSIS 85
5 MARKET OVERVIEW 86
5.1 DRIVERS 88
5.1.1 INCREASING PET OWNERSHIP 88
5.1.2 ADVANCEMENTS IN VETERINARY MEDICINE 88
5.1.3 GROWING INCIDENCES OF PET DISEASES 89
5.1.4 INCREASED GOVERNMENT PROJECTS TO ENHANCE ANIMAL CARE 89
5.2 RESTRAINTS 90
5.2.1 INCREASING PET CARE COSTS 90
5.2.2 STRICT REGULATORY GUIDELINES 90?
5.3 OPPORTUNITIES 91
5.3.1 RISING R&D ACTIVITIES AND PRODUCT APPROVAL FOR VETERINARY PAIN MANAGEMENT 91
5.3.2 RISING POPULARITY OF NON- CONVENTIONAL TREATMENT APPROACHES 92
5.3.3 TECHNOLOGICAL ADVANCEMENTS 92
5.4 CHALLENGES 93
5.4.1 LIMITED AVAILABILITY OF VETERINARIANS 93
5.4.2 RESISTANCE TO MEDICATIONS 93
6 GLOBAL VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE 94
6.1 OVERVIEW 95
6.2 ANALGESICS 96
6.2.1 ANTI- INFLAMMATORY (NSAIDS) 96
6.2.1.1 CARPROFEN 97
6.2.1.2 MELOXICAM 97
6.2.1.3 PHENYLBUTAZONE 97
6.2.1.4 ACETAMINOPHEN 97
6.2.1.5 FIROCOXIB 97
6.2.1.6 DERACOXIB 97
6.2.1.7 OTHERS 98
6.2.2 OPIOIDS 98
6.2.2.1 MU AGONISTS 98
6.2.2.1.1 METHADONE 99
6.2.2.1.2 MEPERIDINE 99
6.2.2.1.3 MORPHINE 99
6.2.2.1.4 OXYMORPHONE 99
6.2.2.1.5 OTHERS 99
6.2.2.2 PARTIAL MU AGONIST 99
6.2.2.2.1 BUPRENORPHINE 99
6.2.2.2.2 OTHERS 100
6.2.2.3 KAPPA AGONIST MU ANTAGONIST 100
6.2.2.3.1 BUTORPHANOL 100
6.2.2.3.2 OTHERS 100
6.3 CORTICOSTEROIDS 101
6.3.1 DEXAMETHASONE 101
6.3.2 PREDNISOLONE 101
6.3.3 PREDNISONE 101
6.3.4 OTHERS 102
6.4 ALPHA 2 AGONISTS 102?
7 GLOBAL VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE 103
7.1 OVERVIEW 104
7.2 BRANDED 105
7.3 GENERIC 105
8 GLOBAL VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE 106
8.1 OVERVIEW 107
8.2 PRESCRIPTION BASED 108
8.3 OTC 108
9 GLOBAL VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 109
9.1 OVERVIEW 110
9.2 COMPANION ANIMAL 111
9.2.1 CANINE 112
9.2.2 EQUINE 112
9.2.3 FELINE 112
9.2.4 OTHERS 112
9.3 PRODUCTION ANIMAL 112
9.3.1 CATTLE 113
9.3.2 SWINE 113
9.3.3 POULTRY 113
9.3.4 FISH 113
9.3.5 OTHERS 113
10 GLOBAL VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE 114
10.1 OVERVIEW 115
10.2 CHRONIC PAIN 116
10.3 ACUTE PAIN 117
10.4 POST OPERATIVE PAIN 117
10.5 DENTAL PAIN 118
11 GLOBAL VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE 119
11.1 OVERVIEW 120
11.2 SOLID 121
11.2.1 TABLET 121
11.2.2 POWDER 122
11.2.3 OTHERS 122
11.3 LIQUID 122
11.3.1 SOLUTION 122
11.3.2 SYRUP 123
11.3.3 SUSPENSION 123
11.3.4 OTHERS 123
11.4 SEMI SOLID 123
11.4.1 GEL 124
11.4.2 CREAM 124
11.4.3 OTHERS 124
12 GLOBAL VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION 125
12.1 OVERVIEW 126
12.2 PARENTERAL 127
12.3 ORAL 128
12.4 TOPICAL 128
13 GLOBAL VETERINARY PAIN MANAGEMENT MARKET, BY END USER 129
13.1 OVERVIEW 130
13.2 VETERINARY HOSPITALS 131
13.3 VETERINARY CLINICS 132
13.4 PET SHOPS 132
13.5 ANIMAL FARMS 133
13.6 ACADEMIC & RESEARCH INSTITUTES 133
13.7 OTHERS 134
14 GLOBAL VETERINARY PAIN MANAGEMENT MARKET, BY GEOGRAPHY 135
14.1 OVERVIEW 136
14.2 NORTH AMERICA 140
14.2.1 U.S. 148
14.2.2 CANADA 155
14.2.3 MEXICO 163
14.3 EUROPE 170
14.3.1 GERMANY 178
14.3.2 FRANCE 185
14.3.3 U K 192
14.3.4 ITALY 199
14.3.5 SPAIN 206
14.3.6 NETHERLANDS 213
14.3.7 RUSSIA 220
14.3.8 SWITZERLAND 227
14.3.9 POLAND 234
14.3.10 BELGIUM 241
14.3.11 TURKEY 248
14.3.12 SWEDEN 255
14.3.13 DENMARK 262
14.3.14 NORWAY 269
14.3.15 FINLAND 276
14.3.16 REST OF EUROPE 283
14.4 ASIA PACIFIC 290
14.4.1 CHINA 298
14.4.2 AUSTRALIA 305
14.4.3 INDIA 312
14.4.4 JAPAN 319
14.4.5 SINGAPORE 326
14.4.6 INDONESIA 333
14.4.7 MALAYSIA 340
14.4.8 NEW ZEALAND 347
14.4.9 SOUTH KOREA 354
14.4.10 VIETNAM 361
14.4.11 THAILAND 368
14.4.12 PHILIPPINES 375
14.4.13 TAIWAN 382
14.4.14 REST OF ASIA-PACIFIC 389
14.5 SOUTH AMERICA 390
14.5.1 BRAZIL 398
14.5.2 ARGENTINA 405
14.5.3 REST OF SOUTH AMERICA 412
14.6 MIDDLE EAST AND AFRICA 413
14.6.1 SOUTH AFRICA 421
14.6.2 SAUDI ARABIA 428
14.6.3 U.A.E. 435
14.6.4 EGYPT 442
14.6.5 ISRAEL 449
14.6.6 KUWAIT 456
14.6.7 OMAN 463
14.6.8 QATAR 470
14.6.9 BAHRAIN 477
14.6.10 REST OF MIDDLE EAST AND AFRICA 484
15 GLOBAL VETERINARY PAIN MANAGEMENT MARKET, COMPANY LANDSCAPE 485
15.1 COMPANY SHARE ANALYSIS: GLOBAL 485
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 486
15.3 COMPANY SHARE ANALYSIS: EUROPE 487
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 488
16 SWOT ANALYSIS 489
17 COMPANY PROFILE 490
17.1 ZOETIS SERVICES LLC 490
17.1.1 COMPANY SNAPSHOT 490
17.1.2 COMPANY SHARE ANALYSIS 490
17.1.3 PRODUCT PORTFOLIO 491
17.1.4 RECENT DEVELOPMENTS 491
17.2 ELANCO 492
17.2.1 COMPANY SNAPSHOT 492
17.2.2 REVENUE ANALYSIS 492
17.2.3 COMPANY SHARE ANALYSIS 493
17.2.4 PRODUCT PORTFOLIO 493
17.2.5 RECENT DEVELOPMENT 493
17.3 MERCK & CO., INC. 494
17.3.1 COMPANY SNAPSHOT 494
17.3.2 REVENUE ANALYSIS 494
17.3.3 COMPANY SHARE ANALYSIS 495
17.3.4 PRODUCT PORTFOLIO 495
17.3.5 RECENT DEVELOPMENT 495
17.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 496
17.4.1 COMPANY SNAPSHOT 496
17.4.2 COMPANY SHARE ANALYSIS 496
17.4.3 PRODUCT PORTFOLIO 497
17.4.4 RECENT DEVELOPMENT 497
17.5 VETOQUINOL 498
17.5.1 COMPANY SNAPSHOT 498
17.5.2 REVENUE ANALYSIS 498
17.5.3 COMPANY SHARE ANALYSIS 499
17.5.4 PRODUCT PORTFOLIO 499
17.5.5 RECENT DEVELOPMENTS 499
17.6 BIMEDA, INC. 501
17.6.1 COMPANY SNAPSHOT 501
17.6.2 PRODUCT PORTFOLIO 501
17.6.3 RECENT DEVELOPMENT 501
17.7 CEVA ANIMAL HEALTH, LLC 502
17.7.1 COMPANY SNAPSHOT 502
17.7.2 PRODUCT PORTFOLIO 502
17.7.3 RECENT DEVELOPMENT 502
17.8 CHANELLE PHARMA 503
17.8.1 COMPANY SNAPSHOT 503
17.8.2 PRODUCT PORTFOLIO 503
17.8.3 RECENT DEVELOPMENT 503
17.9 DECHRA PHARMACEUTICALS PLC 504
17.9.1 COMPANY SNAPSHOT 504
17.9.2 REVENUE ANALYSIS 504
17.9.3 PRODUCT PORTFOLIO 505
17.9.4 RECENT DEVELOPMENTS 505
17.10 DURVET ANIMAL HEALTH PRODUCTS 506
17.10.1 COMPANY SNAPSHOT 506
17.10.2 PRODUCT PORTFOLIO 506
17.10.3 RECENT DEVELOPMENT 506
17.11 INOVET (A SUBSIDIARY OF ORION GROUP) 507
17.11.1 COMPANY SNAPSHOT 507
17.11.2 PRODUCT PORTFOLIO 507
17.11.3 RECENT DEVELOPMENTS 507
17.12 NORBROOK 509
17.12.1 COMPANY SNAPSHOT 509
17.12.2 PRODUCT PORTFOLIO 509
17.12.3 RECENT DEVELOPMENT 509
17.13 VIRBAC 510
17.13.1 COMPANY SNAPSHOT 510
17.13.2 REVENUE ANALYSIS 510
17.13.3 PRODUCT PORTFOLIO 511
17.13.4 RECENT DEVELOPMENT 511
18 QUESTIONNAIRE 512
19 RELATED REPORTS 516
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security